Proteinase-activated receptors in the endometrium and endometriosis

article OA: closed CC0 ⤵ 3 in-corpus citations
AI-generated summary by claude@2026-06, 2026-06-11

PAR₁ and PAR₂ are expressed in endometrial and endometriotic cells, where their activation promotes inflammatory cytokine production, cell proliferation, and matrix metalloproteinase activity.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-11 · read from full text

This review examines proteinase-activated receptors (PARs), focusing on PAR1 and PAR2, their expression in eutopic endometrial cells and endometriotic cells, and the proteinases that activate them, such as thrombin and tryptase. It reports that PAR1 activation in endometrial stromal cells increases vascular endothelial growth factor and matrix metalloproteinase production, and enhances plasminogen activator activities, while PAR2 activation in endometrial stromal cells stimulates IL-8 and stem cell factor production and cell proliferation. In endometriotic stromal cells, the review summarizes that PAR1 activation induces IL-8, monocyte chemotactic protein-1, and cyclooxygenase-2 with increased proliferation, and that PAR2 activation increases IL-6 and IL-8 secretion as well as cell number. As a review, the paper does not present original experiments and instead synthesizes reported findings; this paper is centrally about endometriosis — it focuses specifically on PAR1 and PAR2 functions in the endometrium and endometriotic lesions.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Proteinase-activated receptors (PARs) are G protein-coupled receptors activated by various proteinases. PARs play important roles in haemostasis, thrombosis, and inflammation. PAR₁ and PAR₂ are expressed in endometrial cells from the eutopic endometrium and endometriotic cells derived from endometriotic lesions. A typical activator of PAR₁, thrombin, and a typical activator of PAR₂, tryptase, are produced in the endometrium as well as endometriotic lesions. PAR₁ activation in endometrial stromal cells induces production of vascular endothelial growth factor and matrix metalloproteinases, and increases activities of tissue-type and urokinase-type plasminogen activator. PAR₂ activation in endometrial stromal cells stimulates interleukin (IL)-8 and stem cell factor production and proliferation of the cells. PAR₁ activation in endometriotic stromal cells induces production of IL-8, monocyte chemotactic protein-1, and cyclooxygenase-2, and proliferation of the cells. PAR₂ activation in endometriotic stromal cells increases secretion of IL-6 and IL-8, and the number of the cells. These findings indicate a wide range of function of PAR₁ and PAR₂ in the endometrium and endometriosis, and suggest PAR₁ and PAR₂ as possible therapeutic targets for endometriosis.
Full text 1,897 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

Proteinase-activated receptors (PARs) are G protein-coupled receptors activated by various proteinases. PARs play important roles in haemostasis, thrombosis, and inflammation. PAR1 and PAR2 are expressed in endometrial cells from the eutopic endometrium and endometriotic cells derived from endometriotic lesions. A typical activator of PAR1, thrombin, and a typical activator of PAR2, tryptase, are produced in the endometrium as well as endometriotic lesions. PAR1 activation in endometrial stromal cells induces production of vascular endothelial growth factor and matrix metalloproteinases, and increases activities of tissue-type and urokinase-type plasminogen activator. PAR2 activation in endometrial stromal cells stimulates interleukin (IL)-8 and stem cell factor production and proliferation of the cells. PAR1 activation in endometriotic stromal cells induces production of IL-8, monocyte chemotactic protein-1, and cyclooxygenase-2, and proliferation of the cells. PAR2 activation in endometriotic stromal cells increases secretion of IL-6 and IL-8, and the number of the cells. These findings indicate a wide range of function of PAR1 and PAR2 in the endometrium and endometriosis, and suggest PAR1 and PAR2 as possible therapeutic targets for endometriosis.

Keywords

- Endometrium - Endometriosis - Proteinase-Activated Receptor - Review

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Endometrium Receptor, PAR-1 Receptor, PAR-2 Animals Endometriosis Endometrium Female Humans Receptor, PAR-1 Receptor, PAR-1 Receptor, PAR-2 Receptor, PAR-2

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (3)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-13T06:22:48.782012+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:23.388809+00:00
License: CC0 · commercial use OK